Rating Change
UBS analysts reiterated a Neutral rating on Healthcare Realty Trust Incorporated (NYSE:HR) on July 08, 2026.
Rating Change UBS analysts reiterated a Neutral rating on Healthcare Realty Trust Incorporated (NYSE:HR) on July 08, 2026. Market Context Healthcare Realty Trust Incorporated…

UBS analysts reiterated a Neutral rating on Healthcare Realty Trust Incorporated (NYSE:HR) on July 08, 2026.
Healthcare Realty Trust Incorporated operates in the Real Estate sector. The stock currently trades at $20.63 with a market capitalization of $6.1B.
Analyst coverage from UBS provides professional research and price targets that many institutional investors reference when making allocation decisions. The consensus of analyst opinions — along with the range of price targets — helps frame market expectations for Healthcare Realty Trust Incorporated.
Analyst ratings and price targets are one input among many for investment decisions. Historical studies show that consensus analyst recommendations have mixed predictive power on their own, but significant changes in consensus — such as multiple upgrades or downgrades in a short period — can be more meaningful signals.
Among the 10 most recent ratings: 4 Buy, 6 Hold, 0 Sell.
| Date | Firm | Rating | Price Target |
|---|---|---|---|
| Jul 08, 2026 | UBS | Neutral | N/A |
| Jun 17, 2026 | Raymond James | Outperform | N/A |
| Jun 01, 2026 | Wells Fargo | Equal-Weight | N/A |
| May 14, 2026 | RBC Capital | Sector Perform | N/A |
| May 13, 2026 | UBS | Neutral | N/A |
Related Tools: Analyst Ratings Dashboard | View HR Stock Page
A Neutral rating from UBS reflects the analyst's outlook on Healthcare Realty Trust Incorporated (NYSE:HR). Analyst ratings are one factor investors consider alongside earnings, valuation, and sector trends.
Browse recent upgrades and downgrades on our Analyst Ratings Dashboard or the HR forecast page.
Current market data
NYSE · HR
$19.39
Down: -$0.02 · -0.10%
Live quote updated
Keep reading
dividends ·
analyst ·
earnings ·
analyst ·